mRNA

Vaxxas to advance its microarray patches for COVID vaccination LabOnline02:35Vaxxas Coronavirus Vaccine US Covid Vaccine

Brisbane biotech Vaxxas secures $3.2m from US medical research body BARDA to develop COVID patch Business News Australia07:54Vaxxas Coronavirus Vaccine US Covid Vaccine

US announces new funds for mRNA vaccines, fast tracks bird flu tests MailOnline18:34Flu Pandemics Bird Flu Flu

Bird flu sparks vaccine stock surge: ETFs to watch as H5N1 outbreak intensifies Benzinga18:20Flu Pandemics Bird Flu Flu

Study uncovers why lupus patients have weaker response to COVID-19 vaccines News-Medical.Net12:43Coronavirus Vaccine Global Health

mRESVIA Rsv Vaccine Is a Key Area to Watch for Community Pharmacy in 2025 Pharmacy Times18:45FDA Pharma Global Health

A norovirus vaccine is in the works TIME14:47FDA Pharma Global Health

Factcheck: True: mRNA COVID-19 vaccines are safe and effective New York Amsterdam News05:05Coronavirus Vaccine Fact Check (World) Pandemics

Acuitas Sues GSK Seeking Declaratory Judgment of Invalidity and Non-Infringement of mRNA Vaccine Patents JD Supra19:40Pfizer BioNTech Patent Law

Is Moderna stock a no-brainer buy on the sell-off? The Motley Fool09:59Moderna JPMorgan Chase Biotechnology

Katalin Karikó’s Nobel Prize–Winning Work on mRNA Was Long Ignored—And Led to COVID Vaccines Scientific American18:08Covid Katalin Karikó Nobel Prizes

‘We don’t have a Team Australia approach’: Vaccine facility rejects plea for help The Sydney Morning Herald18:00Australia Moderna New South Wales

Study advocates immunological value of COVID vaccination in mm American Journal of Managed Care15:57T-Cells Coronavirus Vaccine

Sequential sting and CD40 agonism drives massive expansion of tumor-specific T cells in liposomal peptide vaccines Nature.com01:43T-Cells Coronavirus Vaccine

Latest News

In the last 4 hours

HHS Provides $590 Million to Accelerate Pandemic Influenza mRNA-based Vaccine Development, Enhance Platform Capability… U.S. Department of Health and Human Services (Press Release)22:00 17-Jan-25

In the last 6 hours

BioNet Wins BARDA Patch Forward Prize for Microneedle mRNA Vaccine Innovation PR Newswire (Press Release)19:22 17-Jan-25

In the last 7 days

HHS Intends to Provide $211 Million to Accelerate, Enhance Platform Capability for Emerging Infectious Diseases U.S. Department of Health and Human Services (Press Release)19:03 16-Jan-25

US announces new funds for mRNA vaccines, fast tracks bird flu tests MailOnline18:34 16-Jan-25

Study will investigate how AI could speed up vaccine and medicine development University of Strathclyde15:18 16-Jan-25

BioVaxys Advances DPX Technology for mRNA Vaccine Delivery TipRanks12:55 16-Jan-25

Study uncovers why lupus patients have weaker response to COVID-19 vaccines News-Medical.Net12:43 16-Jan-25

BioVaxys Developing DPX to be the Carrier of Choice for mRNA Vaccines, a market projected to… PR Newswire (Press Release)12:00 16-Jan-25

Roche Receives FDA Clearance For New, Highly-Sensitive Test To Aid Clinicians In Diagnosing… Laboratory Network05:19 16-Jan-25

Factcheck: True: mRNA COVID-19 vaccines are safe and effective New York Amsterdam News05:05 16-Jan-25

Vaxxas to advance its microarray patches for COVID vaccination LabOnline02:35 16-Jan-25

mRESVIA RSV Vaccine Is a Key Area to Watch for Community Pharmacy in 2025 Pharmacy Times18:45 15-Jan-25

The mechanism of mRNA cap recognition Nature.com16:58 15-Jan-25

Is Moderna Stock a No-Brainer Buy on the Sell-Off? The Motley Fool09:59 15-Jan-25

SCP-Nano: A new technology to visualize nanocarriers in cells and tissues ScienceDaily00:11 15-Jan-25

UPDATE - Micron Biomedical Wins $2 Million BARDA Competition for Its Collaboration with Zipcode Bio to Develop… GlobeNewswire (Press Release)19:01 14-Jan-25

BioNTech Provides Business and Pipeline Updates at 43rd Annual J.P. Morgan Healthcare Conference GlobeNewswire (Press Release)11:47 14-Jan-25

LTS wins funding from BARDA's Patch Forward Prize Competition for two partnerships PR Leap (Press Release)11:41 14-Jan-25

Brisbane biotech Vaxxas secures $3.2m from US medical research body BARDA to develop COVID patch Business News Australia07:54 14-Jan-25

UQ and Vaxxas win global prize to accelerate patch-based mRNA vaccine for COVID-19 News-Medical.Net03:35 14-Jan-25

UQ and Vaxxas win prize to advance patch-based mRNA COVID-19 vaccine UQ News01:15 14-Jan-25

Vaxxas Named Stage Winner of United States’ BARDA Prize to Advance Microarray Patches for… Business Wire (Press Release)20:08 13-Jan-25

Acuitas Sues GSK Seeking Declaratory Judgment of Invalidity and Non-Infringement of mRNA Vaccine Patents JD Supra19:40 13-Jan-25

Micron Biomedical Wins $2 Million BARDA Competition for Its Collaboration with Zipcode Bio to Develop mRNA-Based Broad… GlobeNewswire (Press Release)19:03 13-Jan-25

BioCina and NovaCina Merger Bolsters Global CDMO Industry PR Newswire (Press Release)16:43 13-Jan-25

Dx&Vx Presents a New Paradigm for Next-Generation Infectious Disease Response with the… PR Newswire (Press Release)14:09 13-Jan-25

Studies by HighField Biopharmaceuticals Show Advantages of Lipid Structure Design for Applying… Business Wire (Press Release)10:31 13-Jan-25

In the last month

Nuclear Speckles Identified as Key Hubs for Gene Expression Regulation Newswise (Press Release)22:37 10-Jan-25

Moderna's former top scientist Moore has a new mRNA startup ENDPOINTS16:11 10-Jan-25

A Norovirus Vaccine Is in the Works TIME14:47 10-Jan-25

Arcturus Therapeutics Announces Initiation of Phase 1 H5N1 Flu Vaccine Trial Business Wire (Press Release)13:08 10-Jan-25

A bivalent Covid-19 mRNA vaccine elicited broad immune responses and protection against Omicron subvariants infection Nature.com01:38 10-Jan-25

Katalin Karikó’s Nobel Prize–Winning Work on mRNA Was Long Ignored—And Led to COVID Vaccines Scientific American18:08 9-Jan-25

etherna Announces Strategic Multi-Target Collaboration with Dropshot Therapeutics PR Newswire (Press Release)15:59 9-Jan-25

Study Advocates Immunological Value of COVID Vaccination in MM American Journal of Managed Care15:57 9-Jan-25

mRNA Cancer Vaccines Clinical Trials Ongoing Research Development Insight GlobeNewswire (Press Release)13:36 9-Jan-25

2024 National Medal of Technology and Innovation Laureates honored at the White House - USPTO ag-IP-news.com08:53 9-Jan-25

Bird Flu Sparks Vaccine Stock Surge: ETFs To Watch As H5N1 Outbreak Intensifies Benzinga18:20 8-Jan-25

RDM16 Alternative Splicing and Liquid-Liquid Phase Separation Contribute to Heat Tolerance in Plants Behavioural and Social Sciences at Nature Research13:37 8-Jan-25

Did Yale Scientists Find COVID-19 Spike Proteins in Vaccinated People? What We Know About Rumor Snopes.com02:33 8-Jan-25

‘We don’t have a Team Australia approach’: Vaccine facility rejects plea for help The Sydney Morning Herald18:00 7-Jan-25

Virbac Introduces URSOLYX™ Soft Chews: Innovation in Canine Muscle Health PR Newswire (Press Release)17:49 7-Jan-25

Newsmax Rising Bestsellers - Week of Jan. 6, 2025 NewsMax21:41 6-Jan-25

Arcturus Therapeutics Announces Initiation of Dosing in Phase 2 Multiple Ascending Dose Studies … Business Wire (Press Release)21:08 6-Jan-25

Social media posts falsely claim Japan named Covid vaccine 'deadliest drug' Yahoo! UK & Ireland02:41 3-Jan-25

Gene expression in the human brain: cell types become more specialized, not just more numerous ScienceDaily22:38 2-Jan-25

The year ahead for RNA therapeutic development and manufacturing European Pharmaceutical Review09:53 2-Jan-25

Engineers target neurons with modified lipid nanoparticles Drug Target Review08:08 2-Jan-25

The guided fire from within: intratumoral administration of mRNA-based vaccines to mobilize memory immunity and direct… Nature.com01:10 2-Jan-25

Sequential sting and CD40 agonism drives massive expansion of tumor-specific T cells in liposomal peptide vaccines Nature.com01:43 1-Jan-25

Altamira Therapeutics Announces Successful Nanoparticle-Based Delivery of Circular RNA GlobeNewswire (Press Release)14:01 31-Dec-24

Self-amplifying mRNA Covid Vaccine: An Introduction Absolutely Maybe Blog08:37 31-Dec-24

Authorization Milestone for First NextGen Covid Vaccine in Europe and More News (Update 24) Absolutely Maybe Blog08:37 31-Dec-24

Getting Ready for More mRNA Vaccine Fear-Mongering: A Compendium Absolutely Maybe Blog06:50 28-Dec-24

IPS Enhances Innovation With Three Expert Process Architects Pharmaceutical Online19:11 27-Dec-24

SLE B cells take an extrafollicular detour after mRNA vaccination Nature.com10:23 27-Dec-24

Therapeutic potential of microglial SMEK1 in regulating H3K9 lactylation in cerebral ischemia-reperfusion Nature.com14:12 26-Dec-24

mRNA Vaccines and Therapeutics Market Expected to Reach USD 253.83 Billion By 2034, With 16.7% CAGR From 2025 to 2034 | … GlobeNewswire (Press Release)07:04 26-Dec-24

WHO TAG-CO-VAC reviews COVID-19 vaccine effectiveness and antigen composition News-Medical.Net10:53 24-Dec-24

Mpox mRNA-1769 vaccine inhibits orthopoxvirus replication at intranasal, intrarectal, and cutaneous sites of inoculation Nature.com05:07 24-Dec-24

Veritas In Silico Partners for mRNA Drug Innovation TipRanks23:31 22-Dec-24

A Cure for Cancer? Russia’s 2024 Vaccine Sparks Hope Greek Reporter10:48 20-Dec-24

CancerVax Passes First Test with Flying Colors GlobeNewswire (Press Release)08:07 20-Dec-24

The mRNA Multiplier: Making the UK a World Leader in a Vital Health Technology The Tony Blair Institute for Global Change00:08 20-Dec-24

Combining long- and short-read sequencing in single cells reveals new mRNAs in neurodegenerative diseases Newswise (Press Release)17:36 19-Dec-24

Marama Labs opens new lab at DCU Alpha and raises €2m in funding Silicon Republic16:07 19-Dec-24

Vigeneron’s mRNA trans-splicing gene therapy for Stargardt disease receives Ind clearance BioWorld16:00 19-Dec-24

Personalis Advances Business Strategy with Investment from Merck and Extends Collaboration with … Business Wire (Press Release)14:10 19-Dec-24

mRNA vaccine from CDC and Moderna protects ferrets from current avian influenza strain FierceBiotech19:15 18-Dec-24

DNA-Based Vaccine Production Provides Best Shot at Profitability Genetic Engineering and Biotechnology News19:10 18-Dec-24

Optimizing TFF for mRNA Filtration Genetic Engineering and Biotechnology News19:10 18-Dec-24

Modified lipid nanoparticles for targeted mRNA delivery to the brain News-Medical.Net17:26 18-Dec-24

Australian Drugs Regulator Knew mRNA Vaccines Can Enter Nucleus and Integrate into Genome Despite Official Denials,… The Daily Sceptic17:11 18-Dec-24

Covid bombshell as scientists discover huge problem with booster jabs Dublin Live15:01 18-Dec-24

Russia Claims To Have Developed Cancer Vaccine, Patients To Get It For Free From 2025 Outlook India14:38 18-Dec-24

ViGeneron Announces FDA Clearance of IND for Novel mRNA Trans-Splicing Gene Therapy VG801 to Treat Stargardt Disease… GlobeNewswire (Press Release)13:03 18-Dec-24

Cartesian Therapeutics Announces New Employment Inducement Grants GlobeNewswire (Press Release)12:11 18-Dec-24

You’ve never heard of the Covid booster with the fewest side effects Vox11:38 18-Dec-24

Russia's cancer vaccine to be available for free from 2025 NewsBytes11:28 18-Dec-24

Russia claims to have developed cancer vaccine, to be free from 2025 Mint06:51 18-Dec-24

view more headlines

17 Jan 22:00

About our mRNA news

Latest news on mRNA (messenger RNA), covering vaccines, therapeutics, research breakthroughs, clinical trials, and biotech companies like Moderna and BioNTech.

Messenger RNA, or mRNA, has revolutionized the fields of vaccine development and medical therapeutics. The technology gained global attention during the COVID-19 pandemic, with the rapid development and deployment of highly effective mRNA-based vaccines from Pfizer-BioNTech and Moderna. As of April 2024, billions of doses of these vaccines have been administered worldwide, significantly reducing the severity and mortality of COVID-19.

Beyond COVID-19, mRNA technology shows immense promise for treating various diseases, including cancer, genetic disorders, and infectious diseases. Ongoing clinical trials are investigating mRNA-based therapies for conditions such as HIV, influenza, and Zika virus. Additionally, researchers are exploring the potential of personalized mRNA cancer vaccines, which could revolutionize cancer treatment by targeting individual patients' unique tumor profiles.

The success of mRNA vaccines has sparked increased interest and investment in the biotech companies leading this innovation. Moderna and BioNTech have seen significant growth and partnerships with major pharmaceutical companies. The technology's versatility has also attracted the attention of philanthropic organizations, such as the Bill and Melinda Gates Foundation, which are funding research to address global health challenges.

The rapid development and success of mRNA vaccines during the COVID-19 pandemic built upon decades of foundational research. Scientists' understanding of mRNA's role in protein synthesis, combined with advancements in lipid nanoparticle delivery systems, paved the way for this breakthrough. The pandemic accelerated the translation of this research into life-saving interventions, demonstrating the importance of sustained investment in basic science.

As mRNA technology continues to advance, it is crucial to stay informed about the latest developments, clinical trial results, and regulatory approvals. Our NewsNow feed on mRNA provides comprehensive, up-to-date coverage from trusted sources, ensuring you have access to the most relevant information on this groundbreaking field and its impact on global health.

Publication filters

Sorry, no headlines or news topics were found. Please try different keywords.